FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1694928582> ?p ?o ?g. }

• W1694928582 abstract "Abstract The last two decades has seen an avalanche of studies establishing Activated protein C (APC) resistance due to Factor V Leiden mutation as the most prevalent genetic risk factor, yet known, for venous thromboembolism. This has been documented in 20-60% of patients with deep vein thrombosis (DVT). Whether such propensity also exists in arterial circulation is still controversial. The general aim of the present thesis is to clearify some of the controversies that cloud the impact of APC resistance or Factor V leiden mutation on arterial thrombosis. Paper I showed a significantly high prevalence of APC resistance or factor V Leiden mutation in peripheral vascular patients compared to the control group (22.7% vs 12.2%). In Paper II, association between early occlusions of vascular reconstructions and Factor V Leiden mutation was shown. At one month, there was a two-fold risk of occlusion of vascular reconstructions compared to non-carriers (14% vs 7%, p=0.02). At one year, the same tendency was noted although not significant (22% vs 12%). Paper III, an experimental arterial thrombosis study with factor V Leiden mice, revealed increased thrombogenicity in mice with Factor V Leiden mutation and arterial injury. There was a significant relationship between time to occlusion (TTO) and genotype (p=0.002). TTO was highest in the wild type mice (TTO: homozygote <heterozygote <wild type; p <0.001). Paper IV analyzing the mortality, amputation rate and inflammatory mediators in critical limb ischemia (CLI) patients with Factor V Leiden did not find any significant difference in inflammatory mediators between critical limb ischemia patients with Factor V Leiden and non-carriers. There was neither a significant difference in the rate of amputation at one year nor mortality up to 10 years between CLI patients with FVL mutation and non-carriers. Conlusions: Resistance to activated protein C or Factor V Leiden mutation is more prevalent in patients with peripheral vascular diseases than the general population, the risk for early occlusions of vascular reconstructions increases two-folds in FVL patients compared to non-carriers and FVL enhances arterial thrombosis development after vessel wall injury in experimental FVL mice. However, no difference in long-term (10 years) mortality or one-year amputation rate is seen between critical limb ischemia patients with FVL mutation and non-carriers. (Less)" @default.
• W1694928582 created "2016-06-24" @default.
• W1694928582 creator A5071937274 @default.
• W1694928582 date "2012-01-01" @default.
• W1694928582 modified "2023-09-26" @default.
• W1694928582 title "Arterial Thrombosis in Factor V Leiden or Activated Protein C Resistance. Clinical and Experimental Studies." @default.
• W1694928582 hasPublicationYear "2012" @default.
• W1694928582 type Work @default.
• W1694928582 sameAs 1694928582 @default.
• W1694928582 citedByCount "0" @default.
• W1694928582 crossrefType "dissertation" @default.
• W1694928582 hasAuthorship W1694928582A5071937274 @default.
• W1694928582 hasConcept C126322002 @default.
• W1694928582 hasConcept C141071460 @default.
• W1694928582 hasConcept C164705383 @default.
• W1694928582 hasConcept C2776046644 @default.
• W1694928582 hasConcept C2777175894 @default.
• W1694928582 hasConcept C2778959117 @default.
• W1694928582 hasConcept C2779936836 @default.
• W1694928582 hasConcept C2779956388 @default.
• W1694928582 hasConcept C2780011451 @default.
• W1694928582 hasConcept C2780868729 @default.
• W1694928582 hasConcept C2781287897 @default.
• W1694928582 hasConcept C50440223 @default.
• W1694928582 hasConcept C71924100 @default.
• W1694928582 hasConcept C90924648 @default.
• W1694928582 hasConceptScore W1694928582C126322002 @default.
• W1694928582 hasConceptScore W1694928582C141071460 @default.
• W1694928582 hasConceptScore W1694928582C164705383 @default.
• W1694928582 hasConceptScore W1694928582C2776046644 @default.
• W1694928582 hasConceptScore W1694928582C2777175894 @default.
• W1694928582 hasConceptScore W1694928582C2778959117 @default.
• W1694928582 hasConceptScore W1694928582C2779936836 @default.
• W1694928582 hasConceptScore W1694928582C2779956388 @default.
• W1694928582 hasConceptScore W1694928582C2780011451 @default.
• W1694928582 hasConceptScore W1694928582C2780868729 @default.
• W1694928582 hasConceptScore W1694928582C2781287897 @default.
• W1694928582 hasConceptScore W1694928582C50440223 @default.
• W1694928582 hasConceptScore W1694928582C71924100 @default.
• W1694928582 hasConceptScore W1694928582C90924648 @default.
• W1694928582 hasLocation W16949285821 @default.
• W1694928582 hasOpenAccess W1694928582 @default.
• W1694928582 hasPrimaryLocation W16949285821 @default.
• W1694928582 hasRelatedWork W1863461785 @default.
• W1694928582 hasRelatedWork W1963496886 @default.
• W1694928582 hasRelatedWork W1964473700 @default.
• W1694928582 hasRelatedWork W1981901592 @default.
• W1694928582 hasRelatedWork W2019873941 @default.
• W1694928582 hasRelatedWork W2064202659 @default.
• W1694928582 hasRelatedWork W2065400177 @default.
• W1694928582 hasRelatedWork W2081338401 @default.
• W1694928582 hasRelatedWork W2088492457 @default.
• W1694928582 hasRelatedWork W2089304893 @default.
• W1694928582 hasRelatedWork W2090094279 @default.
• W1694928582 hasRelatedWork W2090434341 @default.
• W1694928582 hasRelatedWork W2109654476 @default.
• W1694928582 hasRelatedWork W2138936492 @default.
• W1694928582 hasRelatedWork W2166961581 @default.
• W1694928582 hasRelatedWork W2242371531 @default.
• W1694928582 hasRelatedWork W2342715520 @default.
• W1694928582 hasRelatedWork W2952991798 @default.
• W1694928582 hasRelatedWork W2992132036 @default.
• W1694928582 hasRelatedWork W2567110772 @default.
• W1694928582 isParatext "false" @default.
• W1694928582 isRetracted "false" @default.
• W1694928582 magId "1694928582" @default.
• W1694928582 workType "dissertation" @default.